CAR T-Cell Therapy for Glioblastoma

N Engl J Med. 2024 Apr 11;390(14):1329-1332. doi: 10.1056/NEJMe2401307.

Authors

Misty R Jenkins¹, Katharine J Drummond¹

Affiliation

¹ From the Immunology Division, Walter and Eliza Hall Institute, and the Department of Medical Biology, University of Melbourne, Parkville, VIC (M.R.J.), and the Department of Surgery, University of Melbourne, Melbourne, VIC (K.J.D.) - all in Australia.

PMID: 38598802
DOI: 10.1056/NEJMe2401307

No abstract available

Publication types

Editorial

MeSH terms

Brain Neoplasms* / therapy
Cell Line, Tumor
Glioblastoma* / therapy
Humans
Immunotherapy, Adoptive*
Receptors, Antigen, T-Cell / therapeutic use
Receptors, Chimeric Antigen* / therapeutic use

Substances

Receptors, Antigen, T-Cell
Receptors, Chimeric Antigen